Pitbowl Posted - 1 hour ago

$BDX $MRMD - Cannabis Icecream $BMY $CERN $CI https://www.youtube.com/shorts/KsYYrvMNybc

MarketDragon Posted - 2 days ago

Stock Performance for $CI over the Last Month: Opening Price: $343.98 Closing Price: $340.82 Highest Price: $347.37 Lowest Price: $316.55 Percentage Change: -0.92% For more information: https://www.sahg6dtr.com/3K2CLMD/R74QP/

MarketDragon Posted - 3 days ago

Stock Performance for $CI over the Last Month: Opening Price: $342.16 Closing Price: $335.79 Highest Price: $347.37 Lowest Price: $316.55 Percentage Change: -1.86% For more information: https://www.sahg6dtr.com/3K2CLMD/R74QP/

Aigner_Andreas Posted - 6 days ago

TD SELL $CI at 335.84, Supp 319.12 Resis 344.76 R8 HiLo 75% T1Y 314 buy 2.2 DIV 1.42% #Cigna Corp #stocks #trading #finance #market

PIVOTPOINTSMUSA Posted - 1 week ago

$UNH $CI $CVS $JNJ

DonCorleone77 Posted - 1 week ago

$ELV $UNH $CNC $CI $MOH Elevance Health downgraded to Neutral from Buy at BofA BofA analyst Kevin Fischbeck downgraded Elevance Health (ELV) to Neutral from Buy with a price target of $530, down from $646. In Q2, both UnitedHealth (UNH) and Elevance signaled incremental Medicaid pressure, notes the analyst, who sees this making it difficult to have conviction about where and when Medicaid margins will trough. Although some premium is warranted for Elevance, there sees the current gap to peers like Centene (CNC), Cigna (CI) and Molina Healthcare (MOH) limiting the upside, the analyst added.

Katzung Posted - 1 week ago

$CI $UNH up massively from the recent sell offs. A properly timed and executed tarde would mint a fortune fomr someone with good trading discipline. I was exited the Cigna calls soon as I reached my break even price as I no longer wanted to handle the election risk. And kept a tiny position on UNH via calls which I exited soon after the 4.5% pop at market open after earnings. Made a decent gain, but no where near the max potential for that trade. Considering that even Humana is up so much from the near 300ish bottom it hit, these are clearly buy and hold names and stable for long term portfolio. Obviously not the best stocks to trade via short term options unless buying leaps.

optionspayus Posted - 1 week ago

$spy $qqq it’s clear. Trump wants a lower bar for him to easily beat. He will make comments on every issue to shake up the markets. Helps him win if stock market is going down. He will bring those insurance companies down too $unh $ci

optionspayus Posted - 1 week ago

$spy $qqq $unh $CI The insurance companies are sky rocketing and Obama care repeal won’t work well for Rep’s. It implies no Obama care and very high insurance costs

optionspayus Posted - 1 week ago

$SPY $qqq $unh and $ci are rallying… insurance costs appear going high under Trump. A good talking point for Dem’s

FolikoInvest Posted - 1 week ago

$CI A new FTC report has raised concerns about the power of pharmacy benefit managers like Cigna's Express Scripts, who have been accused of inflating drug costs and harming smaller pharmacies and consumers. With the industry facing greater regulation, will this lead to a shake-up of the pharmaceutical sector? https://folikoinsights.com/article/CI/2024/07/16/ftc-report-raises-concerns-over-cigna-and-other-pbms-influence-on-drug-prices-and-consolidation-in-t?rf=stocktwits

Bionicrooster Posted - 1 week ago

$CI

TampaBayBuc Posted - 1 week ago

$CI $10 drop from premarket high $341.

NicholasABrown Posted - 1 week ago

$CI $MRK $TOL $MDT | Merck And 3 Other Cheap Stocks To Buy Ahead Of Earnings - Barron’s “Cigna, Merck, Toll Brothers, Medtronic could see shares gain after proving their earnings growth remains strong.” https://www.barrons.com/articles/cheap-stocks-earnings-merck-toll-medtronic-cigna-16c2e310?st=zjqhdb7izcm4ovn

Americanbulls Posted - 2 weeks ago

$CI apparently the bear pattern is not confirmed. Prices continue to rise. www.Americanbulls.com/SignalPage.aspx?lang=en&Ticker=CI

OpenOutcrier Posted - 2 weeks ago

$UNH $CVS $CI Federal Trade Commission to sue drug middlemen over prices of medications including insulin, source says - CNBC https://ooc.bz/l/37386

Ro_Patel Posted - 2 weeks ago

Rumour: FTC plans to sue the 3 largest PBMs over their negotiating tactics for various medicines, including insulin, that pushed patients toward higher-priced treatments The FTC this week released a scathing report that found the 3 largest PBMs — $CI Express Scripts, $CVS Caremark, & $UNH OptumRx — processed nearly 80% of the roughly 6.6B prescriptions that were dispensed by US pharmacies in 2023. The report found that the prescription drug market is “highly concentrated” b/c the largest PBMs are owned by insurers and, in turn, own specialty, mail-order, or retail pharmacies, which throttles competition. The FTC said its findings were interim, though, b/c some companies did not provide all of the requested information & threatened further action.

aaronwall Posted - 2 weeks ago

FTC suing the PBMs, which is why that interim report was rushed out - as pretext to begin the litigation. https://www.wsj.com/health/pharma/ftc-to-sue-drug-managers-over-insulin-prices-b46af71f $WBA up over 4% while $CVS off a percent. $CI off a half percent & $UNH up over a percent today. There is an ongoing article series in the WSJ https://www.wsj.com/finance/stocks/how-drug-middlemen-keep-beating-the-system-671a638b The “optics are not good and must be addressed,” an executive at a PBM parent organization was quoted as saying in a document obtained by the FTC. “You can get the drug…at a non-preferred pharmacy (Costco) for $97, at Walgreens (preferred) for $9000, and at preferred home delivery for $19,200…Compounding the challenge/optics is the fact that we’ve created plan designs to aggressively steer customers to home delivery where the drug cost is ~200 times higher.” ... In its report, the FTC cites experts who argue that the PBMs may have spun off these rebate aggregators as separate entities to keep more of the savings they create in their pockets instead of passing them on to employers.

USSLiberty Posted - 2 weeks ago

$CI

Mitz007 Posted - 2 weeks ago

$CVS $UNH $CI

DonCorleone77 Posted - 2 weeks ago

$UNH $CI $CVS FTC to sue PBMs over insulin prices, WSJ reports Following a two-year investigation, the Federal Trade Commission plans to file lawsuits against the largest three pharmacy-benefit managers, or PBMs, over their tactics for negotiating prices for drugs including insulin, taking aim at the business practices related to rebates brokered with drug manufacturers, a person familiar with the matter told The Wall Street Journal's Liz Essley Whyte and Anna Wilde Mathews. The three largest PBMs - UnitedHealth Group's (UNH) OptumRx, Cigna's (CI) Express Scripts and CVS Health's (CVS) Caremark - each share a parent with a large health insurer and handle roughly 80% of U.S. prescriptions, the Journal noted

Shant_Is_Back Posted - 2 weeks ago

$CLOV Haha $CVS, $UNH, and $CI Unbowed by Critical FTC Report on Pharmacy Benefit Managers https://www.marketwatch.com/articles/cvs-unh-cigna-ftc-pharmacy-benefit-managers-ee95eeba?mod=mw_latestnews

DonCorleone77 Posted - 2 weeks ago

$CVS $UNH $HUM $CI FTC releases interim staff report on pharmacy benefit managers The Federal Trade Commission announced it has published an interim report on the prescription drug middleman industry that underscores the impact pharmacy benefit managers, or PBMs, have on the accessibility and affordability of prescription drugs. "The interim staff report, which is part of an ongoing inquiry launched in 2022 by the FTC, details how increasing vertical integration and concentration has enabled the six largest PBMs to manage nearly 95 percent of all prescriptions filled in the United States. This vertically integrated and concentrated market structure has allowed PBMs to profit at the expense of patients and independent pharmacists," the FTC stated. The Commission's interim report stems from special orders the FTC issued in 2022, under Section 6(b) of the FTC Act, to the six largest PBMs-Caremark Rx, LLC; Express Scripts, Inc.; OptumRx, Inc.; Humana Pharmacy Solutions, Inc.; Prime Therapeutics LLC; and MedImpact Healthcare Systems, Inc. In 2023, the FTC issued additional orders to Zinc Health Services, LLC, Ascent Health Services, LLC, and Emisar Pharma Services LLC, which are each rebate aggregating entities, also known as "group purchasing organizations," that negotiate drug rebates on behalf of PBMs, the FTC noted.

Katzung Posted - 2 weeks ago

$CI https://www.statnews.com/pharmalot/2024/07/09/pbm-pharmacies-cvs-optum-humana-cigna-pharmaceuticals-medicines-prescriptions-antitrust/ Is this the reason for the pre-market weakness?

Katzung Posted - 2 weeks ago

$CI Trying to bounce off and stay above the 200dma.. hopefully closes above that.

maddy007a Posted - 2 weeks ago

$CI why is this not going up!!! Last week was horrible and this week this is crawling verrrrryyyyy slow!!

maddy007a Posted - 3 weeks ago

$CI all of heathcare is recovering except $CI Hopefully this gets back on now!!!

anil218 Posted - 3 weeks ago

$CI Easy 340+…

Stocksrunner Posted - 3 weeks ago

$CI Cigna's stock options are seeing high implied volatility, suggesting potential market moves. Investors should watch for any news related to their healthcare services and market positioning.

profit_guru Posted - 3 weeks ago

$CI - stock bottomed..expect algo dip buying into close…near term 340…imo